Indre Kucinskaite-Kodze

Dr. Indre Kucinskaite-Kodze

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
SKShweta Kailasan
Shweta Kailasan
JGJamie Garrison
Jamie Garrison
MIMaria Ilyas
Maria Ilyas
PCPaul Chipman
Paul Chipman
RMRobert McKenna
Robert McKenna
MAMavis Agbandje-McKenna
Mavis Agbandje-McKenna
Human bocaviruses (HBoV1 to -4) are emerging pathogens associated with pneumonia and/or diarrhea in young children. Currently, there is no treatment or vaccination, so there is a need to study these pathogens to understand their disease mechanisms on a molecular and structural level for the development of control strategies. Here, we report the structures of six HBoV monoclonal antibody (MAb) fragment complexes, HBoV1-15C6, HBoV2-15C6, HBoV4-15C6, HBoV1-4C2, HBoV1-9G12, and HBoV1-12C1, determined by cryo-electron microscopy and three-dimensional image reconstruction to 18.0- to 8.5-Å resolution. Of these, the 15C6 MAb cross-reacted with HBoV1, HBoV2, and HBoV4, while the 4C2, 12C1, and 9G12 MAbs recognized only HBoV1. Pseudoatomic modeling mapped the 15C6 footprint to the capsid surface DE and HI loops, at the 5-fold axis and the depression surrounding it, respectively, which are conserved motifs in Parvoviridae . The footprints for 4C2, 12C1, and 9G12 span the surface loops that assemble portions of the 2-/5-fold wall (a raised surface feature between the 2-fold and 5-fold axes of symmetry) and the shoulder of the 3-fold protrusions. The MAb footprints, cross reactive and strain specific, coincide with regions with high and low sequence/structural identities, respectively, on the capsid surfaces of the HBoVs and identify potential regions for the development of peptide vaccines for these viruses. IMPORTANCE Human bocaviruses (HBoVs) may cause severe respiratory and gastrointestinal infections in young children. The nonenveloped parvovirus capsid carries determinants of host and tissue tropism, pathogenicity, genome packaging, assembly, and antigenicity important for virus infection. This information is currently unavailable for the HBoVs and other bocaparvoviruses. This study identifies three strain-specific antigenic epitopes on the HBoV1 capsid and a cross-reactive epitope on the HBoV1, HBoV2, and HBoV4 capsids using structures of capsid-antibody complexes determined using cryo-electron microscopy and image reconstruction. This is the first study to report the highly conserved parvovirus DE loop at the 5-fold axis as a determinant of antigenicity. Additionally, knowledge of the strain-specific and conserved antigenic epitopes of the bocaviruses can be instrumental in characterization of the virus life cycle, development of peptide vaccines, and generation of gene delivery vectors for cystic fibrosis given the strict tropism of HBoV1 for human airway epithelial cells.

1 August 2010 in Toxicon
Verified
Journal Article
Closed access
AZAurelija Zvirbliene
Aurelija Zvirbliene
MPMilda Pleckaityte
Milda Pleckaityte
RLRita Lasickiene
Rita Lasickiene
IKIndre Kucinskaite-Kodze
Indre Kucinskaite-Kodze
GZGintautas Zvirblis
Gintautas Zvirblis

Verified
Journal Article
Open access
PDF file
Maryia DrobyshMaryia Drobysh
Maryia Drobysh
VLViktorija Liustrovaite
Viktorija Liustrovaite
ABAusra Baradoke
Ausra Baradoke
ARAlma Rucinskiene
Alma Rucinskiene
Almira RamanavicieneAlmira Ramanaviciene
Almira Ramanaviciene
Arũnas RamanavičiusArũnas Ramanavičius
Arũnas Ramanavičius
The serologic diagnosis of coronavirus disease 2019 (COVID-19) and the evaluation of vaccination effectiveness are identified by the presence of antibodies specific to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this paper, we present the electrochemical-based biosensing technique for the detection of antibodies specific to the SARS-CoV-2 proteins. Recombinant SARS-CoV-2 spike proteins (rSpike) were immobilised on the surface of a gold electrode modified by a self-assembled monolayer (SAM). This modified electrode was used as a sensitive element for the detection of polyclonal mouse antibodies against the rSpike (anti-rSpike). Electrochemical impedance spectroscopy (EIS) was used to observe the formation of immunocomplexes while cyclic voltammetry (CV) was used for additional analysis of the surface modifications. It was revealed that the impedimetric method and the elaborate experimental conditions are appropriate for the further development of electrochemical biosensors for the serological diagnosis of COVID-19 and/or the confirmation of successful vaccination against SARS-CoV-2.

1 January 2016 in Virus Research
Verified
Journal Article
Closed access
IKIndre Kucinskaite-Kodze
Indre Kucinskaite-Kodze
MPMilda Pleckaityte
Milda Pleckaityte
CBCorinna M. Bremer
Corinna M. Bremer
PSPia L. Seiz
Pia L. Seiz
MZMilda Zilnyte
Milda Zilnyte
AZAurelija Zvirbliene
Aurelija Zvirbliene

14 February 2023 in Viruses
Verified
Journal Article
Open access
PDF file
AAAliona Avižinienė
Aliona Avižinienė
IKIndre Kucinskaite-Kodze
Indre Kucinskaite-Kodze
RBRasa Petraityte Burneikiene
Rasa Petraityte Burneikiene
AZAurelija Zvirbliene
Aurelija Zvirbliene
MMMarc L. Mertens
Marc L. Mertens
RURainer Ulrich
Rainer Ulrich
Hantaviruses are emerging pathogens with a worldwide distribution that can cause life-threatening diseases in humans. Monoclonal antibodies (MAbs) against hantavirus nucleocapsid (N) proteins are important tools in virus diagnostics, epidemiological studies and basic research studies on virus replication and pathogenesis. Here, we extend the collection of previously generated MAbs raised against a segment of Puumala orthohantavirus (PUUV) N protein harbored on virus-like particles (VLPs) and MAbs against N proteins of Sin Nombre orthohantavirus/Andes orthohantavirus by generating nine novel MAbs against N proteins of Dobrava-Belgrade orthohantavirus (DOBV), Tula orthohantavirus (TULV), Thottapalayam thottimvirus (TPMV) and PUUV. In order to have a wide collection of well-described hantavirus-specific MAbs, the cross-reactivity of novel and previously generated MAbs was determined against N proteins of 15 rodent- and shrew-borne hantaviruses by different immunological methods. We found that all MAbs, excluding TPMV-specific MAbs, demonstrated different cross-reactivity patterns with N proteins of hantaviruses and recognized native viral antigens in infected mammalian cells. This well-characterized collection of cross-reactive hantavirus-specific MAbs has a potential application in various fields of hantavirus research, diagnostics and therapy.

15 May 2022 in Viruses
Verified
Journal Article
Open access
PDF file
LWLina Widerspick
Lina Widerspick
CVCecilia Alejandra Vazquez
Cecilia Alejandra Vazquez
LNLinda Niemetz
Linda Niemetz
MHMichelle Heung
Michelle Heung
COCatherine Olal
Catherine Olal
Beatriz Escudero-PérezBeatriz Escudero-Pérez
Beatriz Escudero-Pérez
Nipah virus (NiV) is an emerging zoonotic paramyxovirus that causes severe disease in humans and livestock. Due to its high pathogenicity in humans and the lack of available vaccines and therapeutics, NiV needs to be handled in biosafety level 4 (BSL-4) laboratories. Safe inactivation of samples containing NiV is thus necessary to allow further processing in lower containment areas. To date, there is only limited information available on NiV inactivation methods validated by BSL-4 facilities that can be used as a reference. Here, we compare some of the most common inactivation methods in order to evaluate their efficacy at inactivating NiV in infected cells, supernatants and organs. Thus, several physical and chemical inactivation methods, and combinations thereof, were assessed. Viral replication was monitored for 3 weeks and NiV presence was assessed by RT-qPCR, plaque assay and indirect immunofluorescence. A total of nineteen methods were shown to reduce NiV infectious particles in cells, supernatants and organs to undetectable levels. Therefore, we provide a list of methods for the safe and efficient inactivation of NiV.